Clinical and Visual Field Outcomes Following Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery

Marcus L Turner,1 Abu M Taha,1 Sean Yonamine,1 Yinxi Yu,2 Murtaza Saifee,1 Mike Yang,3 Gui-Shuang Ying,2 Ying Han,1 Julius T Oatts1 1Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA; 2Department of Ophthalmology, Perelman School of Medicine, University of...

Full description

Bibliographic Details
Main Authors: Turner ML, Taha AM, Yonamine S, Yu Y, Saifee M, Yang M, Ying GS, Han Y, Oatts JT
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/clinical-and-visual-field-outcomes-following-minimally-invasive-glauco-peer-reviewed-fulltext-article-OPTH
_version_ 1811206681156124672
author Turner ML
Taha AM
Yonamine S
Yu Y
Saifee M
Yang M
Ying GS
Han Y
Oatts JT
author_facet Turner ML
Taha AM
Yonamine S
Yu Y
Saifee M
Yang M
Ying GS
Han Y
Oatts JT
author_sort Turner ML
collection DOAJ
description Marcus L Turner,1 Abu M Taha,1 Sean Yonamine,1 Yinxi Yu,2 Murtaza Saifee,1 Mike Yang,3 Gui-Shuang Ying,2 Ying Han,1 Julius T Oatts1 1Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA; 2Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; 3Prism Eye Institute, Oakville, ON, CanadaCorrespondence: Julius T Oatts, Department of Ophthalmology, University of California, San Francisco, 490 Illinois Street, San Francisco, CA, 94158, USA, Tel +1 415 353 2800, Fax +1 415 353 2468, Email julius.oatts@ucsf.eduPurpose: To determine the change in Humphrey visual field and clinical parameters after minimally invasive glaucoma surgery combined with cataract surgery.Patients and Methods: Patients undergoing minimally invasive glaucoma surgery combined with cataract surgery in a multicenter retrospective case series between 2013 and 2021 with reliable preoperative and 12 to 18 month postoperative visual field measurements were included. Devices included iStent, XEN, and Hydrus. Clinical parameters were compared with a generalized linear model with generalized estimating equations between preoperative and postoperative visits including best corrected visual acuity, intraocular pressure, number of glaucoma medications and visual fields. Visual field metrics included mean deviation (MD), pattern standard deviation (PSD), visual field index (VFI), and Collaborative Initial Glaucoma Treatment Study (CIGTS) score of total deviation probability and pattern deviation probability.Results: Forty-four eyes from 39 patients were included. During the follow up period, visual acuity improved from 0.23± 0.17 to 0.10± 0.14 logMAR (mean ± standard deviation, p< 0.001), number of glaucoma medications was reduced from 2.68± 1.06 to 1.46± 1.32 (p< 0.001), and intraocular pressure decreased from 17.08± 4.23 mmHg to 14.92± 3.13 mmHg (p=0.003). Differences across devices were negligible. The only significant difference was a greater reduction in number of glaucoma medications in the XEN group (p< 0.001). There were no significant changes in the global parameters of VFI, MD, PSD, or CIGTS.Conclusion: Overall, minimally invasive glaucoma surgery combined with cataract surgery appears to be effective at stabilizing visual field function, reducing intraocular pressure, reducing number of glaucoma medications, and improving visual acuity over a 12 to 18 month follow-up period across MIGS devices.Keywords: glaucoma, MIGS, visual field, cataract
first_indexed 2024-04-12T03:51:21Z
format Article
id doaj.art-f5849ef8934a4f048e6f26ade9723695
institution Directory Open Access Journal
issn 1177-5483
language English
last_indexed 2024-04-12T03:51:21Z
publishDate 2022-09-01
publisher Dove Medical Press
record_format Article
series Clinical Ophthalmology
spelling doaj.art-f5849ef8934a4f048e6f26ade97236952022-12-22T03:48:58ZengDove Medical PressClinical Ophthalmology1177-54832022-09-01Volume 163193320378647Clinical and Visual Field Outcomes Following Minimally Invasive Glaucoma Surgery Combined with Cataract SurgeryTurner MLTaha AMYonamine SYu YSaifee MYang MYing GSHan YOatts JTMarcus L Turner,1 Abu M Taha,1 Sean Yonamine,1 Yinxi Yu,2 Murtaza Saifee,1 Mike Yang,3 Gui-Shuang Ying,2 Ying Han,1 Julius T Oatts1 1Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA; 2Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; 3Prism Eye Institute, Oakville, ON, CanadaCorrespondence: Julius T Oatts, Department of Ophthalmology, University of California, San Francisco, 490 Illinois Street, San Francisco, CA, 94158, USA, Tel +1 415 353 2800, Fax +1 415 353 2468, Email julius.oatts@ucsf.eduPurpose: To determine the change in Humphrey visual field and clinical parameters after minimally invasive glaucoma surgery combined with cataract surgery.Patients and Methods: Patients undergoing minimally invasive glaucoma surgery combined with cataract surgery in a multicenter retrospective case series between 2013 and 2021 with reliable preoperative and 12 to 18 month postoperative visual field measurements were included. Devices included iStent, XEN, and Hydrus. Clinical parameters were compared with a generalized linear model with generalized estimating equations between preoperative and postoperative visits including best corrected visual acuity, intraocular pressure, number of glaucoma medications and visual fields. Visual field metrics included mean deviation (MD), pattern standard deviation (PSD), visual field index (VFI), and Collaborative Initial Glaucoma Treatment Study (CIGTS) score of total deviation probability and pattern deviation probability.Results: Forty-four eyes from 39 patients were included. During the follow up period, visual acuity improved from 0.23± 0.17 to 0.10± 0.14 logMAR (mean ± standard deviation, p< 0.001), number of glaucoma medications was reduced from 2.68± 1.06 to 1.46± 1.32 (p< 0.001), and intraocular pressure decreased from 17.08± 4.23 mmHg to 14.92± 3.13 mmHg (p=0.003). Differences across devices were negligible. The only significant difference was a greater reduction in number of glaucoma medications in the XEN group (p< 0.001). There were no significant changes in the global parameters of VFI, MD, PSD, or CIGTS.Conclusion: Overall, minimally invasive glaucoma surgery combined with cataract surgery appears to be effective at stabilizing visual field function, reducing intraocular pressure, reducing number of glaucoma medications, and improving visual acuity over a 12 to 18 month follow-up period across MIGS devices.Keywords: glaucoma, MIGS, visual field, cataracthttps://www.dovepress.com/clinical-and-visual-field-outcomes-following-minimally-invasive-glauco-peer-reviewed-fulltext-article-OPTHglaucomamigsvisual fieldcataract
spellingShingle Turner ML
Taha AM
Yonamine S
Yu Y
Saifee M
Yang M
Ying GS
Han Y
Oatts JT
Clinical and Visual Field Outcomes Following Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery
Clinical Ophthalmology
glaucoma
migs
visual field
cataract
title Clinical and Visual Field Outcomes Following Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery
title_full Clinical and Visual Field Outcomes Following Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery
title_fullStr Clinical and Visual Field Outcomes Following Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery
title_full_unstemmed Clinical and Visual Field Outcomes Following Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery
title_short Clinical and Visual Field Outcomes Following Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery
title_sort clinical and visual field outcomes following minimally invasive glaucoma surgery combined with cataract surgery
topic glaucoma
migs
visual field
cataract
url https://www.dovepress.com/clinical-and-visual-field-outcomes-following-minimally-invasive-glauco-peer-reviewed-fulltext-article-OPTH
work_keys_str_mv AT turnerml clinicalandvisualfieldoutcomesfollowingminimallyinvasiveglaucomasurgerycombinedwithcataractsurgery
AT tahaam clinicalandvisualfieldoutcomesfollowingminimallyinvasiveglaucomasurgerycombinedwithcataractsurgery
AT yonamines clinicalandvisualfieldoutcomesfollowingminimallyinvasiveglaucomasurgerycombinedwithcataractsurgery
AT yuy clinicalandvisualfieldoutcomesfollowingminimallyinvasiveglaucomasurgerycombinedwithcataractsurgery
AT saifeem clinicalandvisualfieldoutcomesfollowingminimallyinvasiveglaucomasurgerycombinedwithcataractsurgery
AT yangm clinicalandvisualfieldoutcomesfollowingminimallyinvasiveglaucomasurgerycombinedwithcataractsurgery
AT yinggs clinicalandvisualfieldoutcomesfollowingminimallyinvasiveglaucomasurgerycombinedwithcataractsurgery
AT hany clinicalandvisualfieldoutcomesfollowingminimallyinvasiveglaucomasurgerycombinedwithcataractsurgery
AT oattsjt clinicalandvisualfieldoutcomesfollowingminimallyinvasiveglaucomasurgerycombinedwithcataractsurgery